Trump's win sparks contraception rush among US women
Donald Trump has won the presidential election in the United States, and in January, he will move into the White House for his second term. The effects of his victory are already becoming apparent, as American women are flocking to pharmacies in large numbers to purchase emergency contraception.
2:18 PM EST, November 14, 2024
Donald Trump has fulfilled his goal, securing the presidency by defeating the Democrat Kamala Harris. After a four-year hiatus, he will return to the White House for what will be his second and final term. The emotions surrounding this right-wing politician are high, particularly among people in the United States, and understandably so. "The Trump Effect" is already visible, despite the fact that he will not take office until January 2025. One area affected by this phenomenon is emergency contraception.
It's well-known that Donald Trump holds very strong views on abortion and women's rights. He has openly expressed his desire to see abortion completely banned. It is likely that he will attempt to restrict access to emergency contraception, which remains legal in the USA. This possibility has alarmed women across the country, prompting them to visit pharmacies en masse.
"The Trump Effect" already visible in the USA
American women are concerned that once Donald Trump officially becomes president, access to emergency contraception will become more complex. Many have rushed to pharmacies to ensure they have an adequate supply. This trend is especially noticeable in states where abortion rights are already restricted. The online pharmacy Winx Health reported a more than 990 percent increase in sales of the Restart pill within the first 60 hours following the election compared to the previous week.
The surge in demand doesn't stop at emergency contraception. There's also a significant increase in interest in permanent contraceptive methods. The non-profit organization Planned Parenthood announced on social media that since Wednesday, November 6th, the number of appointments for the insertion of intrauterine devices has jumped by 760 percent, and for contraceptive implants, by 350 percent.
